SAYER KEVIN R
SEC CIK 1286858 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DXCM | Dexcom | Pres, CEO, COB, Dir | 302.2K | — | $77.32M | 37 | 2021-09-09 | 2026-08-20 |
Most active insiders at DXCM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| 2 | Leach Jacob Steven | Pres, COO | $1.00M | — |
| 3 | Brown Michael Jon | EVP, CLO | — | $873.4K |
| 4 | Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| 5 | AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| 6 | FOLETTA MARK G | Dir | — | $627.2K |
| 7 | Collins Richard Alexander | Dir | — | $389.4K |
| 8 | Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| 9 | Heller Bridgette P | Dir | — | $277.7K |
| 10 | Stern Sadie | EVP, Chief HR Off | — | $226.7K |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-24 16:01 | 2026-08-20 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | S - Sale | $90.01 | -26.8K | 302.2K | -8% | -$2.41M |
| T | 2026-07-21 16:58 | 2026-07-20 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | S - Sale | $76.32 | -26.8K | 329.0K | -8% | -$2.04M |
| T | 2026-07-07 16:09 | 2026-07-06 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | S - Sale | $72.00 | -26.8K | 355.7K | -7% | -$1.93M |
| T | 2026-05-26 16:18 | 2026-05-21 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | S - Sale | $72.00 | -26.8K | 382.5K | -7% | -$1.93M |
| 2026-03-10 | 2026-03-08 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | F - Tax | $68.10 | -32.5K | 409.2K | -7% | -$2.21M | |
| 2026-03-10 | 2026-03-08 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | A - Grant | $0.00 | +32.7K | 441.7K | +8% | $0 | |
| 2026-02-02 | 2026-01-29 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | A - Grant | $0.00 | +71.2K | 443.2K | +19% | $0 | |
| 2026-02-02 | 2026-01-29 | DXCM | Dexcom | SAYER KEVIN R | Executive COB, Dir | F - Tax | $73.36 | -34.3K | 409.0K | -8% | -$2.51M | |
| 2025-03-14 | 2025-03-12 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $70.38 | -32.5K | 372.0K | -8% | -$2.29M | |
| 2025-03-11 | 2025-03-08 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | A - Grant | $0.00 | +85.5K | 404.5K | +27% | $0 | |
| 2025-01-30 | 2025-01-28 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | A - Grant | $0.00 | +68.5K | 352.4K | +24% | $0 | |
| 2025-01-30 | 2025-01-29 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $86.91 | -33.4K | 319.0K | -9% | -$2.90M | |
| M | 2024-04-10 | 2024-04-08 | DXCM | Dexcom | SAYER KEVIN R | COB, Pres CEO, Dir | S - Sale | $138.30 | -49.6K | 306.3K | -14% | -$6.86M |
| M | 2024-03-14 | 2024-03-12 | DXCM | Dexcom | SAYER KEVIN R | COB, Pres CEO, Dir | S - Sale | $133.36 | -81.0K | 372.4K | -18% | -$10.80M |
| 2024-03-11 | 2024-03-08 | DXCM | Dexcom | SAYER KEVIN R | COB, Pres CEO, Dir | A - Grant | $0.00 | +51.7K | 414.5K | +14% | $0 | |
| 2024-01-17 | 2024-01-12 | DXCM | Dexcom | SAYER KEVIN R | Pres, CEO, COB, Dir | A - Grant | $0.00 | +72.7K | 400.2K | +22% | $0 | |
| 2024-01-17 | 2024-01-16 | DXCM | Dexcom | SAYER KEVIN R | Pres, CEO, COB, Dir | S - Sale | $123.63 | -37.3K | 362.8K | -9% | -$4.61M | |
| M | 2023-04-05 | 2023-04-03 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $114.46 | -20.8K | 327.5K | -6% | -$2.38M |
| M | 2023-03-14 | 2023-03-10 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | D - Sale to Iss | $111.40 | -37.5K | 348.3K | -10% | -$4.18M |
| 2023-03-10 | 2023-03-08 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | A - Grant | $0.00 | +54.4K | 385.8K | +16% | $0 | |
| M | 2023-03-02 | 2023-03-01 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $109.94 | -38.5K | 331.3K | -10% | -$4.23M |
| M | 2023-01-31 | 2023-01-30 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $106.15 | -56.8K | 369.8K | -13% | -$6.03M |
| 2023-01-24 | 2023-01-20 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $105.75 | -45.6K | 426.6K | -10% | -$4.82M | |
| 2023-01-20 | 2023-01-18 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | A - Grant | $0.00 | +90.7K | 472.3K | +24% | $0 | |
| 2023-01-20 | 2022-11-03 | DXCM | Dexcom | SAYER KEVIN R | Pres CEO, COB of, Dir | G - Gift | $0.00 | -10.0K | 381.5K | -3% | $0 | |
| M | 2022-03-17 | 2022-03-15 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $409.77 | -3,000 | 98.2K | -3% | -$1.23M |
| M | 2022-03-10 | 2022-03-09 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | D - Sale to Iss | $406.06 | -9,985 | 107.7K | -8% | -$4.05M |
| 2022-03-10 | 2022-03-08 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | A - Grant | $0.00 | +16.3K | 110.9K | +17% | $0 | |
| 2022-02-15 | 2022-02-14 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $418.04 | -3,000 | 94.6K | -3% | -$1.25M | |
| M | 2022-01-20 | 2022-01-18 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $435.56 | -22.7K | 97.6K | -19% | -$9.88M |
| 2022-01-20 | 2022-01-18 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | A - Grant | $0.00 | +38.6K | 117.3K | +49% | $0 | |
| M | 2021-12-17 | 2021-12-15 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $535.97 | -3,000 | 83.4K | -3% | -$1.61M |
| 2021-11-16 | 2021-11-12 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | G - Gift | $0.00 | -3,000 | 87.7K | -3% | $0 | |
| M | 2021-11-16 | 2021-11-15 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $647.84 | -3,000 | 84.7K | -3% | -$1.94M |
| M | 2021-10-18 | 2021-10-15 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $549.22 | -6,000 | 95.7K | -6% | -$3.30M |
| M | 2021-09-16 | 2021-09-15 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $540.58 | -6,000 | 100.1K | -6% | -$3.24M |
| M | 2021-09-13 | 2021-09-09 | DXCM | Dexcom | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $541.36 | -3,017 | 102.7K | -3% | -$1.63M |
Purchase Sale Sale after option exercise All abbreviations